Cerebral infarcts in the setting of eosinophilia: three cases and a discussion.
暂无分享,去创建一个
[1] Matthew W. Martinez,et al. Cardiac magnetic resonance imaging of eosinophilic endomyocardial disease. , 2008, International journal of cardiology.
[2] A. Tefferi,et al. Eosinophilia: secondary, clonal and idiopathic , 2006, British journal of haematology.
[3] J. Harley,et al. Neurologic dysfunction in the idiopathic hypereosinophilic syndrome. , 1985, Annals of internal medicine.
[4] J. Seward,et al. Clinical and echocardiographic features of hypereosinophilic syndromes. , 2000, The American journal of cardiology.
[5] B. Engelmann,et al. bloodjournal.hematologylibrary.org at PENN STATE UNIVERSITY on February 23, 2013. For personal use only. , 2006 .
[6] S. Wolff,et al. THE HYPEREOSINOPHILIC SYNDROME: Analysis of Fourteen Cases With Review of The Literature , 1975, Medicine.
[7] S. Kwon,et al. Sequential magnetic resonance imaging findings in hypereosinophilia-induced encephalopathy , 2001, Journal of Neurology.
[8] M. Hiroe,et al. Ultrastructural features of the endomyocardium in patients with eosinophilic heart disease. An endomyocardial biopsy study. , 1984, Japanese circulation journal.
[9] D. Rosing,et al. Cardiovascular manifestations of hypereosinophilic syndromes. , 2007, Immunology and allergy clinics of North America.
[10] Brian Walters,et al. Cardiotoxicity of the cancer therapeutic agent imatinib mesylate , 2006, Nature Medicine.
[11] A. Tefferi,et al. FIP1L1-PDGFRA in eosinophilic disorders: prevalence in routine clinical practice, long-term experience with imatinib therapy, and a critical review of the literature. , 2006, Leukemia research.
[12] Wei-Lun Chang,et al. Hypereosinophilic syndrome with recurrent strokes: a case report. , 2008, Acta neurologica Taiwanica.
[13] J. Geng,et al. The principal eosinophil peroxidase product, HOSCN, is a uniquely potent phagocyte oxidant inducer of endothelial cell tissue factor activity: a potential mechanism for thrombosis in eosinophilic inflammatory states. , 2006, Blood.
[14] H. Gralnick,et al. NIH conference. The idiopathic hypereosinophilic syndrome. Clinical, pathophysiologic, and therapeutic considerations. , 1982, Annals of internal medicine.